Scanarini M
Divisione di Neurochirurgia, Complesso Convenzionato, Ospedale-Università di Padova.
Minerva Endocrinol. 1990 Jan-Mar;15(1):13-5.
The structural modifications to PRL-secreting pituitary adenomas induced by medical treatment with bromocryptine are described. Whereas the consistency of the tumour diminishes after a shgort period of treatment, making surgical removal easier, it increases after a long period (years) owing to interstitial fibrosis phenomena that impede surgical removal.
描述了用溴隐亭药物治疗对分泌催乳素的垂体腺瘤所引起的结构改变。在短期治疗后肿瘤的质地变软,使手术切除更容易,但在长期(数年)治疗后,由于间质纤维化现象阻碍手术切除,肿瘤质地又会变硬。